AZD8329 is primarily researched for its potential therapeutic applications in the field of cardiovascular diseases. It functions as a selective inhibitor of an enzyme involved in the regulation of blood pressure and vascular tone, making it a candidate for the treatment of hypertension and related conditions. Studies have explored its efficacy in reducing blood pressure and improving vascular function in preclinical models. Additionally, its mechanism of action suggests potential benefits in managing heart failure and other cardiovascular disorders by promoting vasodilation and reducing cardiac workload. Ongoing research aims to further evaluate its safety, efficacy, and potential as a novel treatment option in cardiovascular medicine.